Literature DB >> 1433738

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.

F L Brancati1, J C Whittle, P K Whelton, A J Seidler, M J Klag.   

Abstract

OBJECTIVE: To investigate whether the excess incidence of diabetic end-stage renal disease (ESRD) among African Americans could be explained by racial differences in putative ESRD risk factors.
DESIGN: Population-based, ecologic study using the 1981 and 1982 Maryland Statewide Household Hypertension Survey for data on risk factor prevalence. PARTICIPANTS: A total of 2.1 million adults residing within the boundaries of the Maryland Regional ESRD Registry, grouped by race and ZIP code into 26 subpopulations. MAIN OUTCOME MEASURE: Incidence rates of treatment for diabetic ESRD between 1980 and 1985 from the Maryland Regional ESRD Registry by subpopulation.
RESULTS: Between 1980 and 1985, 442 persons entered treatment for diabetic ESRD. At the level of the subpopulation, diabetic ESRD incidence was positively associated with black race (relative risk [RR], 3.42; 95% confidence interval [CI], 2.84 to 4.13), prevalence of diabetes (RR, 2.35; 95% CI, 1.92 to 2.87), prevalence of poorly controlled hypertension (RR, 1.80; 95% CI, 1.45 to 1.86), lack of a regular source of health care (RR, 1.82; 95% CI, 1.62 to 2.05), and lower socioeconomic status as indicated by lack of college education (RR, 1.41; 95% CI, 1.32 to 1.52) (all, P < .0001). After adjusting for these risk factors, black race remained strongly associated with the overall incidence of diabetic ESRD (RR, 2.70; 95% CI, 1.89 to 3.86; P < .0001). Further analyses suggested that this excess risk among blacks was confined to ESRD related to non-insulin-dependent diabetes (RR, 4.80; 95% CI, 3.09 to 7.46; P < .0001); blacks were at no higher risk than were whites for ESRD related to insulin-dependent diabetes (RR, 0.90; 95% CI, 0.52 to 1.55; P = .70).
CONCLUSIONS: These data suggest that the excess incidence of diabetic ESRD among blacks is not fully explained by a higher prevalence of diabetes or hypertension in blacks or by racial differences in age, socioeconomic status, or access to health care. Instead, they suggest an increased susceptibility to ESRD resulting from non-insulin-dependent diabetes among blacks as compared with whites.

Entities:  

Mesh:

Year:  1992        PMID: 1433738

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  56 in total

1.  Limitations in the use of race in the study of disease causation.

Authors:  R S Cooper; V L Freeman
Journal:  J Natl Med Assoc       Date:  1999-07       Impact factor: 1.798

2.  Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Kelsey Smith; Michael Epstein; Neha Patel; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2010-06-07       Impact factor: 5.992

3.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

4.  Racial and ethnic disparities in end stage renal disease: access failure.

Authors:  Yoshio N Hall
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

5.  Race differences in access to health care and disparities in incident chronic kidney disease in the US.

Authors:  Kira Evans; Josef Coresh; Lori D Bash; Tiffany Gary-Webb; Anna Köttgen; Kathryn Carson; L Ebony Boulware
Journal:  Nephrol Dial Transplant       Date:  2010-08-05       Impact factor: 5.992

6.  Poverty and racial disparities in kidney disease: the REGARDS study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; George Howard; Nataliya Volkova; Paul Audhya; David G Warnock
Journal:  Am J Nephrol       Date:  2010-05-31       Impact factor: 3.754

7.  The need and demand for renal replacement therapy in ethnic minorities in England.

Authors:  P J Roderick; V S Raleigh; L Hallam; N P Mallick
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

8.  Neighborhood poverty and racial differences in ESRD incidence.

Authors:  Nataliya Volkova; William McClellan; Mitchel Klein; Dana Flanders; David Kleinbaum; J Michael Soucie; Rodney Presley
Journal:  J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 10.121

Review 9.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 10.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.